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Abstract
 
The functional properties of dendritic cells (DCs) are strictly dependent on their maturational
state. To analyze the influence of the maturational state of DCs on priming and differentiation
 
of T cells, immature CD83
 
2
 
 and mature CD83
 
1
 
 human DCs were used for stimulation of na-
ive, allogeneic CD4
 
1
 
 T cells. Repetitive stimulation with mature DCs resulted in a strong ex-
pansion of alloreactive T cells and the exclusive development of T helper type 1 (Th1) cells. In
contrast, after repetitive stimulation with immature DCs the alloreactive T cells showed an ir-
reversibly inhibited proliferation that could not be restored by restimulation with mature DCs
or peripheral blood mononuclear cells, or by the addition of interleukin (IL)-2. Only stimula-
tion of T cells with mature DCs resulted in an upregulation of CD154, CD69, and CD70,
whereas T cells activated with immature DCs showed an early upregulation of the negative
regulator cytotoxic T lymphocyte–associated molecule 4 (CTLA-4). These T cells lost their
 
ability to produce interferon 
 
g
 
, IL-2, or IL-4 after several stimulations with immature DCs and
differentiated into nonproliferating, IL-10–producing T cells. Furthermore, in coculture exper-
iments these T cells inhibited the antigen-driven proliferation of Th1 cells in a contact- and
dose-dependent, but antigen-nonspecific manner. These data show that immature and mature
DCs induce different types of T cell responses: inflammatory Th1 cells are induced by mature
DCs, and IL-10–producing T cell regulatory 1–like cells by immature DCs.
Key words: dendritic cells • regulatory T cells • T helper type 1 cells • interleukin 10 • T cell 
differentiation
 
Introduction
 
Dendritic cells (DCs)
 
1
 
 are professional APCs specialized for
the initiation of T cell immunity (1–3). Depending on their
maturational state and their location, DCs perform different
functions within the immune system. DCs normally reside
in nonlymphoid tissues such as the skin in an immature
form, where they are specialized for antigen capture. Acti-
vation of DCs and subsequent migration from nonlym-
phoid tissues to regional lymph nodes have been shown to
be early steps during inflammatory processes and critical
events in the generation of cell-mediated immune re-
sponses against various pathogens. After antigen uptake, in-
flammatory stimuli are necessary to switch DCs to a T cell
stimulatory mode. This process has been called “matura-
tion” and is associated with changes in the phenotype and
function of DCs, including upregulation of costimulatory
molecules and adhesion molecules, expression of chemo-
kine receptors, and migration to the regional lymph nodes
where DCs interact with recirculating T cells and initiate T
cell immunity (1–7).
The activation of CD4
 
1
 
 T cells by antigen-presenting
DCs leads to their differentiation into distinct populations
of effector cells differing in their cytokine secretion pattern
(8, 9). The induction of a polarized T cell phenotype oc-
curs at an early stage of the immune response and is influ-
enced by the cytokine milieu during the priming process,
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the nature and intensity of TCR-mediated activation, co-
stimulatory signals, the genetic background, and the type of
APC involved (10–13). DCs play a critical role in initiating
primary T cell responses and are promising as “nature’s ad-
juvant” for therapeutic applications in humans (14). There-
fore, it is important to define the influence of different DC
subpopulations on the generation of different T cell pheno-
types. In this study, we investigated whether the differenti-
ation state of DCs can influence the polarization of the T
cell response. Therefore, we generated two well-defined
populations of monocyte-derived DCs: immature DCs
(iDCs)
 
 
 
cultured only with GM-CSF and IL-4 (15), and
mature CD83
 
1
 
 DCs (mDCs) generated by additional stim-
ulation with a defined maturation cocktail (16). Both DC
populations generated from the same donors were used for
repetitive stimulation of allogeneic, naive cord blood–
derived CD4
 
1
 
 T cells. We analyzed the phenotype, prolif-
erative capacity, cytokine profile, and functional properties
of polarized T cells. Here we report that iDCs and mDCs
induce completely different T cell phenotypes: inflamma-
tory Th1 responses induced by mDCs versus the polariza-
tion-forward, nonproliferative, IL-10–producing regula-
tory T (Tr) cells by iDCs.
 
Materials and Methods
 
Culture Medium.
 
X-VIVO-15 supplemented with 1% autolo-
gous plasma was used for culture of DCs. T cells were cultured
and stimulated in X-VIVO-20 (both from BioWhittaker).
 
Cytokines.
 
All cytokines used in this study were recombinant
human proteins and were used at plateau concentrations to induce
the optimal generation of DCs. The final concentrations were:
800 U/ml GM-CSF (Leukomax; Sandoz), 1,000 U/ml IL-4 and
IL-6 (Strathmann Biotech GmbH), 10 ng/ml IL-1
 
b 
 
and
 
 
 
TNF-
 
a
 
(Strathmann Biotech GmbH), and 1 
 
m
 
g/ml PGE
 
2
 
 (Minprostin;
Amersham Pharmacia Biotech). 50 U/ml IL-2 (Proleukin; Chi-
ron Corp.) was used for the culture and expansion of T cells.
 
Abs.
 
For immunostaining, the mouse IgGs used were CD1a,
CD2, CD14, CD19, CD40, CD58, CD80, CD86, CD83, and
CD152 (Coulter/Immunotech); the rat IgG used was anti–HLA-
DR (YE2/36HLK; Serotec/Camon). Mouse and rat subclass–
specific isotypes were from Coulter/Immunotech. The conju-
gated secondary reagents used were: FITC-conjugated goat
anti–mouse IgG, and PE-conjugated goat anti–rat IgG (Jackson
ImmunoResearch Laboratories). For the staining of MACS-
sorted T cells, the secondary reagents used were: FITC- or PE-
conjugated CD3, CD4, CD8, CD25, CD28, CD69, CD70,
CD152, and CD154 FITC- and PE-conjugated mouse IgG
(Coulter/Immunotech). PE-conjugated anti–inducible costimu-
lator (ICOS) mAb F44 was provided by Dr. Kroczek (Robert
Koch Institute, Berlin, Germany). The anti–TGF-
 
b
 
 (R&D Sys-
tems; used according to the instructions of the manufacturer) and
anti–IL-10 mAbs (JES-19F1.1.1; American Type Culture Collec-
tion; blocking capacity tested in proliferation assays using IL-10R–
transfected Baf3 cells) were used for blocking experiments.
 
Cytokine Assays.
 
T cells were stimulated with allogeneic DCs
(10
 
6
 
 T cells plus 10
 
5
 
 DCs) in 24-well plates in 1 ml X-VIVO-20.
Cytokine synthesis was determined by the analysis of supernatants
48 h after stimulation. The commercially available ELISA kits for
the human cytokines IFN-
 
g
 
, IL-2, IL-4, IL-5, and IL-10 (BD
PharMingen) were used as indicated by the manufacturer. For in-
 
tracellular analysis of cytokine production, anti–IL-2–PE, anti–
IL-4–PE, anti–IL-5–PE, anti–IL-10–PE, anti–IFN-
 
g
 
–PE mAbs,
and FITC/PE-conjugated isotypic mAb (BD PharMingen) were
used according to the manufacturer’s instructions. In brief, 6 d af-
ter restimulation, 10
 
6
 
 T cells were activated with 2.4 
 
m
 
g/ml PHA
plus 1 ng/ml PMA for 6 h. Monensin (1.3 
 
m
 
M/ml) was added for
the last 4 h, and cells were collected, washed, fixed/saponin per-
meabilized (perm/fix solution; BD PharMingen), and stained
with 0.5 
 
m
 
g/test of cytokine-specific Abs.
 
Generation of DCs.
 
DCs were generated from leukapheresis
products as described previously (15, 17). In brief, PBMCs were
isolated by Ficoll density gradient centrifugation and stored fro-
zen in aliquots. For each DC preparation, frozen PBMCs were
thawed, and monocytes were isolated by plastic adherence and
cultured in X-VIVO-15 plus 1% heat-inactivated autologous
plasma including 800 U/ml GM-CSF and 1,000 U/ml IL-4. At
day 5, nonadherent cells were rinsed off, washed once in PBS,
and transferred to 6-well plates at 7 
 
3 
 
10
 
5
 
 cells in 3 ml/well. For
differentiation into mDCs, iDCs were additionally stimulated on
day 6 with 10 ng/ml IL-1
 
b
 
, 10 ng/ml TNF-
 
a
 
, 1,000 U/ml IL-6,
and 1 
 
m
 
g/ml PGE
 
2
 
 (16). Nonadherent iDCs and mDCs at day 7
were used for T cell stimulation.
 
Flow Cytometric Analysis.
 
Immunofluorescence staining was
performed after washing the cells twice with PBS plus 0.5% hu-
man serum albumin. Cells were incubated for 20 min at 4
 
8
 
C with
each mAb diluted to the optimal concentration for immunostain-
ing. After washing with cold PBS/human serum albumin, the
cells were incubated with FITC- and PE-conjugated second step
mAb for 20 min at 4
 
8
 
C, washed three times, and analyzed by
flow cytometry (FACSCalibur™ and CELLQuest™ software;
Becton Dickinson). Necrosis versus apoptosis was determined by
propidium iodide and annexin V staining according to the in-
structions of the manufacturer (BD PharMingen).
 
Induction of Alloreactive T Cell Lines.
 
Naive CD4
 
1
 
 T cells
were purified from cord blood using CD4 MACS beads as indi-
cated by the manufacturer (Miltenyi Biotec; purity: 
 
.
 
98%
CD4
 
1
 
, 
 
.
 
90% CD45RA
 
1
 
). Alternatively, naive CD4
 
1
 
 T cells
were positive selected from the peripheral blood of healthy adults
using a CD4/CD45RA Multisort kit (Miltenyi Biotec). 10
 
6
 
 T
cells were cultured with 10
 
5
 
 iDCs or mDCs in 1 ml X-VIVO-20
in 24-well plates. Alloreactive T cells were expanded from day 6
in the presence of 50 U/ml IL-2. 2 wk after priming, T cells were
restimulated with iDCs or mDCs from the same donor as in pri-
mary culture under identical culture conditions and expanded
from day 3 on with IL-2 followed by weekly repetitive stimula-
tions under identical culture conditions. Aliquots of the cultures
were used for proliferation assays carried out in X-VIVO-20 with
5 
 
3
 
 10
 
4
 
 T cells/well and different numbers of allogeneic iDCs/
mDCs in 96-well plates. T cell proliferation was measured after
4 d of incubation and an additional 16-h pulse with [
 
3
 
H]TdR (37
kBq/well) using a liquid scintillation counter. For some experi-
ments, the T cells were depleted from 48-h cocultures with
mDCs using CD2 beads (10 beads/cell; Dynal). After depletion
of T cells, the mDCs were used for stimulation of Th1 cells.
 
Transwell Experiments.
 
Transwell experiments were done in
24-well plates. 10
 
6
 
 Th1 or Tr1 cells were stimulated with 10
 
5
 
mDCs or iDCs. Additionally, 10
 
6
 
 Tr1 cells plus 10
 
5
 
 mDCs were
either added directly to the cultures of activated Th1 cells or were
placed in Transwell chambers (Millicell, 0.4 
 
m
 
m; Millipore) in
the same well. After 4 d of culture, activated T cells (10
 
5
 
 cells/
well) were transferred to 96-well plates in triplicates. Proliferation
was measured after an additional 16-h pulse with [
 
3
 
H]TdR using
a liquid scintillation counter. 
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Results
 
Suppressed Proliferation of Alloreactive T Cells Primed with
iDCs.
 
To analyze the influence of the maturational state
of DCs on the priming and differentiation of naive T cells,
we generated alloreactive CD4
 
1
 
 T cell lines by repetitive
stimulations with iDCs or mDCs from the same donor.
Two well-defined DC populations were used: CD83
 
2
 
iDCs generated in the presence of GM-CSF and IL-4, and
terminally differentiated CD83
 
1
 
 mDCs after an additional
stimulation with a defined cytokine cocktail (TNF-
 
a
 
, IL-
1
 
b
 
, IL-6, and PGE
 
2
 
). Although both populations expressed
the costimulatory molecules CD80 and CD86, the expres-
sion of these molecules by mDCs was more homogeneous
and significantly higher compared with iDCs (Fig. 1). Fur-
thermore, the expression of HLA-DR was 10 times higher
on mDCs, and only mDCs showed a homogeneous ex-
pression of CD58.
mDCs as well as iDCs were used for repetitive stimula-
tions of naive cord blood–derived CD4
 
1
 
 T cells. Priming
and repetitive restimulations with mDCs resulted in a
strong proliferation of alloreactive T cells (Fig. 2) and a 30–
50-fold expansion after two rounds of restimulation. In
contrast, iDCs induced only a weak proliferation of allore-
active T cells in the primary culture, and the antigen-
driven proliferation further decreased in the successive re-
stimulations (Fig. 2), finally resulting in nonproliferative
CD4
 
1
 
 T cells. Therefore, it was not possible to induce sta-
ble alloreactive T cell lines or a significant expansion of
these T cells with allogeneic iDCs. The number of T cells
also decreased slowly after repetitive stimulations. 40–60%
of the initial T cell numbers could be recovered after two
rounds of restimulation. However, neither significant ne-
crosis nor apoptosis was observed in the cultures by propid-
ium iodide and annexin V staining (data not shown).
 
Irreversibly Impaired Proliferation of Alloreactive T Cells
Primed with iDCs.
 
To analyze the proliferative capacity of
alloreactive T cell lines induced by iDCs or mDCs in more
detail, primed alloreactive T cells were restimulated with
different APCs from the same donor. As shown in Fig. 3, T
cells primed with mDCs also expanded in the presence of
iDCs or allogeneic PBMCs (data not shown). This suggests
that iDCs do not inhibit the proliferation of primed allore-
active T cells or induce T cell death. In contrast, alloreac-
tive T cells primed with iDCs showed only a marginal pro-
Figure 1. Phenotype of iDCs and mDCs. iDCs were generated from
leukapheresis products by culture of adherent monocytes for 6 d in
X-VIVO-15 plus 1% autologous plasma in the presence of GM-CSF and
IL-4 (left panels); maturation of DCs was induced by stimulation with a
cocktail of proinflammatory cytokines and PGE2 for 24 h (right panels).
Surface expression of both populations was analyzed at day 7. The results
were similar in 10 independent experiments.
Figure 2. Proliferation of alloreactive CD41 T cells induced by iDCs
or mDCs. Naive CD41 T cells purified by MACS sorting from cord
blood were primed and restimulated (every week) with allogeneic iDCs
or mDCs from the same donor (DC/T cell ratio of 1:10) in serum-free
X-VIVO-20. Proliferation of alloreactive T cells (5 3 104/well, triplicate
cultures) was determined by [3H]TdR incorporation. A representative re-
sult of four independent experiments is shown.
Figure 3. Cross-stimulation of alloreactive T cells induced with iDCs
or mDCs. Naive CD41 T cells were primed with allogeneic iDCs or
mDCs from the same donor at a DC/T cell ratio of 1:10. T cells were re-
stimulated two times under the same conditions as in the primary culture.
7 d after the second restimulation, alloreactive T cells primed with iDCs
were cultured with mDCs, and alloreactive T cells primed with mDCs
were cultured with iDCs (5 3 104 T cells/well, triplicate cultures). Prolif-
eration of T cells was determined by the addition of [3H]TdR after 4 d of
coculture. Similar results were obtained in three independent experiments. 
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liferation even after optimal restimulation with mDCs. In
addition, this suppressed capacity for antigen-specific pro-
liferation induced by repetitive restimulation with iDCs
could not be restored in the presence of allogeneic PBMCs
or by addition of 100 U/ml IL-2 (data not shown). Thus,
priming and repetitive restimulation with iDCs induced an
irreversibly inhibited capacity of antigen-driven prolifera-
tion in alloreactive CD4
 
1
 
 T cells.
 
Different Phenotype of Alloreactive T Cells After Activation
with iDCs or mDCs.
 
To further characterize the alloreac-
tive T cell lines, the expression of various surface molecules
on activated T cells was analyzed. Both T cell populations
primed with iDCs or mDCs showed a homogeneous ex-
pression of CD3 and CD4, and no contaminating cells such
as CD14
 
1
 
 monocytes were detectable. Both T cell popula-
tions expressed CD25, CD95, and CD28, and showed an
upregulation of ICOS (18; Fig. 4). In contrast, only T cell
lines induced by iDCs showed a significant upregulation of
CTL-associated molecule (CTLA)-4 (CD152), the high af-
finity counterreceptor of B7-1 and B7-2 that delivers a
negative signal and inhibits T cell proliferation, IL-2 pro-
duction, and cell cycle progression (19–21). This CTLA-4
expression was constantly detectable even 14 d after restim-
ulation, suggesting that these T cells expressed CTLA-4
constitutively (data not shown). In contrast, no upregula-
tion of CD152 on T cells primed with mDCs was detected.
Furthermore, both T cell populations upregulated CD25,
but only T cell lines activated by mDCs showed an en-
hanced expression of the activation molecules CD69,
CD70, and CD154 (CD40 ligand). CD70 costimulates
CD4
 
1
 
 T cells to produce IL-2 and IFN-
 
g
 
, and cross-link-
ing of CD70 also upregulates the expression of CD154 on
activated T cells (22, 23). Furthermore, CD154–CD40 in-
teraction was shown to be a critical signal for T cell and
DC activation (24–26). Thus, the different phenotypes of
activated T cells induced by iDCs or mDCs correlate with
the different rates of expansion. Furthermore, the pheno-
type of differentiated T cells was strictly dependent on the
stimulator cells used for priming. After the second restimu-
lation with iDCs, the irreversibly differentiated T cells in-
duced by iDCs expressed the same phenotype described in
Fig. 4 even upon restimulation with mDCs (data not
shown). Therefore, phenotypic alterations of T cells after
priming with iDCs cannot be easily explained as the direct
result of an insufficient stimulation.
 
Induction of IL-10–producing T Cells by iDCs and Th1 Cells
by mDCs.
 
CD4
 
1
 
 T cell subsets can be distinguished ac-
cording to their ability to produce distinct patterns of cy-
tokines. To analyze the cytokine profiles of alloreactive T
cell lines after repetitive stimulation with iDCs or mDCs,
supernatants of activated T cells were tested by ELISA. In
addition, intracellular cytokine staining of CD4-sorted T
cells was performed to determine the percentage of cells re-
leasing a certain cytokine. As shown in Fig. 5, mDCs in-
duced a strong differentiation of naive CD4
 
1
 
 T cells into
Th1 cells. Such T cells produce large amounts of IFN-
 
g
 
 af-
ter priming with mDCs and showed a typical Th1 cytokine
profile after several restimulations (large amounts of IFN-
 
g
 
and IL-2 but no production of IL-4, IL-5, or IL-10). In
contrast, naive T cells primed and restimulated with alloge-
neic iDCs showed a Th0 cytokine profile after the first re-
stimulation (synthesis of intermediate amounts of IFN-
 
g
 
and IL-4). After repetitive stimulation with iDCs, the al-
loreactive T cells lost their capacity to synthesize IFN-
 
g
 
,
IL-2, and IL-4, indicating that these T cells did not differ-
entiate into Th2 cells, but showed, however, an enhanced
production of IL-10. Thus, the respective T cell progeny
exhibited a cytokine profile characteristic of Tr1 cells, i.e.,
synthesis of high amounts of IL-10 and no or negligible
production of IFN-
 
g
 
, IL-2, IL-4, or IL-5.
 
IL-10–producing T Cells Induced by iDCs Suppress Antigen-
driven Proliferation of Th1 Cells.
 
To analyze the functional
properties of IL-10–producing Tr1-like cells, coculture ex-
periments with alloreactive Th1 cell lines were performed.
To this end, alloreactive Th1 cell lines were restimulated
with mDCs in the presence of different numbers of Tr1-
like cells (also stimulated with mDCs) from the same do-
nor. As shown in Fig. 6, Tr1-like cells suppressed the pro-
liferation of syngeneic Th1 cells in response to allogeneic
Figure 4. Phenotype of alloreactive T cells after stimulation with allo-
geneic DCs. Naive CD41 T cells were primed and restimulated with al-
logeneic iDCs or mDCs from the same donor. The phenotype of CD41
T cells 42 h after coculture with allogeneic DCs (first restimulation) is
shown (representative result of seven independent experiments). 
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mDCs in a dose-dependent manner. At a Th1/Tr1 ratio of
1:1, the proliferation of Th1 cells is reduced to nearly the
level of proliferation of the activated Tr1-like cells alone
(Tr1-like cells plus mDCs, ratio of 1:10; Fig. 6). The ob-
servation that activated Tr1-like cells produce high levels of
the immunosuppressive cytokine IL-10 and no T cell
growth–promoting cytokines such as IL-2 and IL-4 sug-
gests that the inhibitory effect of Tr1-like cells on the pro-
liferation of Th1 cells might be a direct result of soluble in-
hibitory factors produced by activated Tr1-like cells. To
test this hypothesis, alloreactive Th1 and Tr1-like cells
were stimulated with allogeneic iDCs or mDCs. Addition-
ally, alloreactive Tr1-like cells were either added directly to
cocultures of activated Th1 cells or placed in Transwell
chambers in the same well and activated with mDCs. The
semipermeable polycarbonate membrane allows the free
exchange of soluble factors but excludes direct cell contact
of Th1 and Tr1-like cells. As shown in Fig. 7, alloreactive
Th1 cell lines proliferated in the presence of allogeneic
mDCs as well as in the presence of allogeneic iDCs. In
contrast, Tr1-like cells with low proliferative capacity
showed only weak rates of expansion, independent of the
antigen-presenting population used. Furthermore, in cocul-
 
ture, Tr1-like cells suppressed the proliferation of Th1 cells
almost to the level of Tr1-like cells induced by mDCs.
This suggests that the proliferation of the cocultured Th1
cells is almost completely blocked. The separation of both
T cell lines in Transwell chambers virtually abolished this
immunosuppressive effect of Tr1-like cells. These results
suggest that direct cell contact of Tr1 and Th1 cells is es-
sential for the inhibitory capacity of Tr1-like cells. The
comparatively low counts in Transwell experiments resulted
from the experimental procedure (preculture in 24-well
Transwell plates and transfer to 96-well plates at day 4) and
is not a result of weak stimulatory capacity of mDCs in
these assays.
 
The Inhibitory Effect of Tr1-like Cells Is Antigen Nonspecific
and Can Be Partially Reversed by Addition of High Doses of
IL-2.
 
The Th1-inhibitory properties of Tr1-like cells
could be mediated either directly via a Tr1-like/Th1 inter-
action via surface or soluble molecules or, alternatively, via
the downregulation of the costimulatory capacity of target
mDCs by Tr1-like cells. To test the latter possibility, we
stimulated Th1 cells with mDCs preincubated with Tr1-
like cells for 48 h. Fig. 8 A illustrates that such mDCs ex-
erted the same stimulatory capacity as untreated mDCs.
Figure 5. Induction of IL-10–
producing CD41 T cells by allo-
geneic iDCs. 106 naive cord
blood CD41 T cells were cul-
tured with allogeneic iDCs or
mDCs at a DC/T cell ratio of
1:10 in serum-free medium. Re-
petitive stimulations under the
same conditions were repeated
weekly. Cytokines in the super-
natants (right) were detected by
ELISA 48 h after restimulation.
The induced cytokine profiles
(left) were also analyzed by intra-
cellular staining of activated T
cells. Cells were collected and
washed 6 d after coculture with
allogeneic DCs and activated
with 2.4 mg/ml PHA plus 1 ng/
ml PMA for 6 h. Monensin
(1.33  mM/ml) was added for the
last 4 h of culture. The cells were
fixed and stained for detection
of intracellular cytokines using
FITC- or PE-conjugated specific
mAbs. Cytokine profiles and
production after the first and af-
ter the third restimulation are
shown. One of six experiments
with similar results is shown.1218 Immature Dendritic Cells Induce IL-10–producing CD41 T Cells
This finding clearly argues against the assumption that the
Th1-suppressive properties of Tr1-like cells are the conse-
quence of a suppression of the costimulatory capacity of
mDCs by Tr1-like cells.
In the next series of experiments, we investigated
whether Tr1-like and Th1 cells have to interact with target
structures expressed by the same mDCs. Therefore, we
used Th1 and Tr1-like cells generated from the same donor
by priming with mDCs/iDCs from two different donors, A
and B. As shown above, donor A–specific Tr1-like cells
suppressed the proliferation of donor A–specific Th1 cells
in coculture. Furthermore, donor B–specific Tr1 cells also
suppressed the proliferation of donor A–specific Th1 cells
in the presence of donor A and donor B mDCs (Fig. 8 B).
The results suggest that the Th1-inhibitory capacity of
Tr1-like cells does not require the simultaneous presenta-
tion of the target antigens on the same mDCs. Neverthe-
less, activation of Tr1-like cells by the respective target
mDCs is an essential prerequisite, as the incubation of do-
nor A–specific Th1 cells with donor B–specific Tr1-like
cells solely in the presence of donor A–derived mDCs did
not lead to an inhibition of Th1 proliferation.
Transwell chamber experiments indicated that direct cell
contact is essential for the Th1-inhibitory properties of
Tr1-like cells (Fig. 7). However, this experiment cannot
exclude the involvement of membrane-bound molecules
like CTLA-4 and cytokines like IL-10 and TGF-b, which
might be upregulated as a consequence of such a direct cell
contact. Fig. 8 C demonstrates that neither neutralizing
mAbs directed against IL-10 and TGF-b nor blocking
mAbs binding to CTLA-4 could reverse the inhibitory ca-
Figure 6. Inhibition of antigen-specific proliferation of Th1 cells after
coculture with Tr1-like cells. Th1 and Tr1 cell lines were induced by re-
petitive stimulation of naive CD41 T cells with allogeneic mDCs (Th1 cy-
tokine profile) or iDCs (Tr1 cytokine profile) at DC/T cell ratios of 1:10.
7 d after the third restimulation, the Th1 cells (5 3 104 cells/well) were re-
stimulated with mDCs (5 3 103 cells/well) in the presence of different
numbers of Tr1-like cells from the same cord blood fraction induced with
iDCs from the same DC donor. Proliferation of T cells was determined by
[3H]TdR incorporation after 4 d of culture. *Background proliferation of
Tr1-like cells plus mDCs. One of three experiments is shown.
Figure 7. The inhibitory effect of Tr1-like cells on the proliferation of
Th1 cells requires direct cell contact. T cells with a Th1 or Tr1 cytokine
profile were induced by repetitive stimulations of naive cord blood–
derived CD41 T cells with allogeneic mDCs or iDCs from the same do-
nor. 7 d after the third restimulation, 106 Th1/Tr1 cells were stimulated
with 105 allogeneic iDCs or mDCs in 24-well Transwell plates. Addition-
ally, 106 Tr1 cells were added directly to the coculture of Th1 plus mDCs
or were placed in Transwell chambers in the same well with 105 mDCs.
After 4 d of culture, 105 activated T cells/well were transferred in 96-well
plates to measure incorporation of [3H]TdR for the final 16 h. Results
representative of three independent experiments are presented as mean
cpm of triplicate determinations.
Figure 8. The inhibitory effect of Tr1-like cells was antigen nonspe-
cific and partially reversible by the addition of IL-2. (A) Day 7 mDCs
were cultured for 48 h alone or in the presence of Tr1-like cells. Thereaf-
ter, T cells were depleted using CD2 beads and the resulting mDCs
(mDC[pre]; 104/well) were used for stimulation of alloreactive Th1 cells
(105 cells/well) compared with untreated mDCs. (B) Polarized Th1 cells
and Tr1-like cells from the same donor were induced by repetitive stimu-
lation of naive T cells with either allogeneic iDCs/mDCs from donor A
(Tr1a/Th1a) or donor B (Tr1b/Th1b). Both T cell populations (105 cells/
well) were cocultured after the second restimulation in the presence of
mDCs (104 cells/well) from donor A and/or donor B as indicated. (C) 10
mg/ml anti–IL-10, 2 mg/ml anti–TGF-b, and 10 mg/ml anti–CTLA-4
were added at the onset of the cultures that were prepared as described
under B. After 4 d of culture, [3H]TdR was added for an additional 16 h.
Results representative of three independent experiments are presented as
mean cpm of triplicate determinations.1219 Jonuleit et al.
pacity of Tr1-like cells. By contrast, the addition of rela-
tively high amounts of IL-2 (100 U/ml) restored the prolif-
eration of Th1 cells at least partially (z70%). As the
proliferation of Tr1-like cells could not be induced with
such amounts of IL-2, this result suggests that Tr1-like cells
suppress the proliferation of Th1 cells, possibly via the inhi-
bition of endogenous IL-2 production.
Discussion
The capacity of DCs to initiate or modulate immune re-
sponses appears to depend on their phenotype and func-
tional maturation. In this study, we compared the influence
of different maturational states of DCs on the differentia-
tion of naive CD41 T cells. To address this issue, we used
monocyte-derived DCs, as this is a particularly well-
defined model (15, 17). iDCs can be generated from
monocytes by culture in GM-CSF plus IL-4, and converted
into mDCs by providing an appropriate stimulus (15–17).
We used a defined cytokine cocktail that reliably induces fully
mature, Th1-inducing DCs (16). We show that mDCs in-
duce the strong expansion of T cells with a polarization to-
wards Th1 cells in concordance with previous findings
(16). In contrast, repetitive stimulation of naive cord
blood–derived T cells with allogeneic iDCs resulted in the
induction of nonexpanding, IL-10–producing T cells.
These T cells suppressed the alloantigen-driven prolifera-
tion of syngeneic Th1 cells in cocultures in a contact and
dose-dependent manner and were therefore termed Tr1-
like cells. Remarkably, this downregulation of Th1 re-
sponses by these Tr1-like cells occurred even upon stimu-
lation of Th1 lines by potent immunostimulatory mDCs.
Detailed analyses revealed that the suppressor function of
such Tr1-like cells is antigen nonspecific and is probably
based on an APC-independent mechanism. Moreover,
suppression does not require that the target antigens are
presented by the same APCs. Finally, blocking of CTLA-4
or endogenous IL-10 and TGF-b has no effect, whereas
the addition of IL-2 could at least partially overcome the
Tr1-like–mediated suppression.
Regarding the development of IL-10–producing T cells,
it has been shown that the addition of IL-10 to primary
murine T cell cultures resulted in the generation of such T
cells (27). In addition, Assenmacher et al. (28) have shown
that the treatment of IFN-g–producing murine CD41 T
cells with IL-4 within the first 3 wk after priming led to the
development of IL-10–producing T cells that lost their ca-
pacity to produce IFN-g or IL-4. To the best of our
knowledge, this study is the first report that shows the reli-
able induction of human Tr cells in vitro. Remarkably, we
find that a particular APC type, namely iDC, is able to in-
duce IL-10–producing CD41 T cells with regulatory prop-
erties in the absence of exogenous cytokines. Naive human
T cells stimulated with allogeneic iDCs initially produced
IFN-g and IL-4 but lost their potential to produce either
IFN-g or IL-4 after the subsequent restimulations with
iDCs (Fig. 5). Taking into account the data of Assen-
macher et al. (28), one might speculate that a possible
mechanism for the induction of IL-10–producing Tr1-like
cells in the presence of iDCs is the conversion of human
IFN-g producers into IL-10 producers by transiently pro-
duced endogenous IL-4. Of note is that ongoing studies in-
dicate that the iDCs we used do not produce significant
amounts of IL-10 (data not shown).
The suppressive properties of the human IL-10–produc-
ing Tr1-like cells as outlined herein suggest that they are
the human counterpart of a recently described population
of murine Tr cells. These cells arise from the thymus of na-
ive mice, express CD4, CD25, and CTLA-4, and their ac-
tivation via the B7-CD28 pathway is thought to be essen-
tial for induction and survival in the periphery (29–34).
They comprise z5–10% of the peripheral CD41 T cells
and could not be induced to proliferate in vitro upon poly-
clonal activation using plate-bound anti-CD3 mAb (29–
31). Regarding their physiological function, it has been
shown that such T cells are involved in the maintenance of
peripheral tolerance (29). The data dealing with the mech-
anism of the suppressive properties of murine Tr cells are
controversial. Groux et al. (27) have shown by using neu-
tralizing Abs that the suppression appears primarily medi-
ated by IL-10 and TGF-b, readily explaining why separat-
ing the Tr1 cells in Transwell chambers from the
alloreactive T cells did not abolish the suppressive effect on
the latter. In sharp contrast, Thornton and Shevach have
shown that the suppression is cytokine independent but
mediated through direct cell–cell contact (35). These dis-
crepancies might be due to the existence of different types
of Tr cells, but also to differences in the experimental de-
sign. Groux et al. (27), for example, have used allogeneic
monocytes as APCs, which are sensitive to the inhibitory
effects of IL-10 for stimulation of both populations, e.g.,
downregulation of the costimulatory capacity of monocytes
by IL-10 led to an impaired T cell proliferation. Using IL-
10–insensitive mDCs (36, 37), we showed that the sup-
pressive effect of human Tr1-like cells required cell–cell
contact. The effect was virtually abolished when Tr1-like
cells were separated from Th1 cells in Transwell chambers.
In agreement with these data, Thornton and Shevach (38)
have also observed a cell contact–dependent, cytokine-
independent mechanism for the suppressive effect of their
murine Tr cells stimulated with anti-CD3 mAb. In addi-
tion, we showed that the inhibitory properties of human
Tr1-like cells were antigen nonspecific and did not require
that the antigens recognized by Tr1-like cells and Th1 cells
were presented on the same APCs. These findings are also
in agreement with data shown by Thornton and Shevach
for murine Tr cells (38). Thus, human IL-10–producing T
cells induced by repetitive stimulations with iDCs showed
many similarities to the murine CD41CD251 T cells de-
scribed by Thornton and Shevach (38).
A characteristic marker of murine Tr cells is the consti-
tutive expression of CTLA-4. This negative regulatory
CD28 homologue on activated T cells is critical for the in-
duction of Tr cells (30, 31). In agreement with these re-
ports, an early upregulation of CTLA-4 on activated T cells
could be observed after stimulation with iDCs but not after1220 Immature Dendritic Cells Induce IL-10–producing CD41 T Cells
stimulation with mDCs (39, 40). It has been reported that
the function of murine Tr cells is dependent on the expres-
sion of CTLA-4 and the production of TGF-b (32, 33).
Blockade of TGF-b in vivo led to an abrogation of T cell–
mediated suppression and induction of severe colitis (33).
In contrast, in our hands the suppressive properties of hu-
man Tr1-like cells could not be inhibited by blocking
CTLA-4 or TGF-b in vitro. Therefore, we suggest that
different molecular mechanisms involving additional sur-
face molecules are responsible for the suppressive properties
of human Tr1-like cells in vitro. Indeed, Takahashi et al.
(32) also postulated that blockade of other surface mole-
cules different from CTLA-4 could abrogate the suppres-
sive activity of murine CD41CD251 T cells.
Additional regulatory elements that influence the inter-
action of T cells and DCs are the CD27/CD70 and CD40/
CD154 pathways, members of the TNF family critical for
T cell activation and differentiation. It was shown that
CD27/CD70 costimulation of naive T cells (like B7/
CD28) enhanced the production of IL-2 and IFN-g and
furthermore induced the upregulation of CD154 on T cells
(22, 23). Cross-linking of CD40 by CD154-expressing T
cells is an efficient stimulus for DCs, leading to IL-12 pro-
duction and upregulation of CD80, CD86, and other T
cell stimulatory molecules (24–26). Furthermore, DC-
derived IL-12 costimulates the proliferation of T cells, and
IL-12 is also a key factor for directing the differentiation of
naive T cells towards Th1 cells (11). In agreement with
these data, we observed upregulation of CD70 and subse-
quent upregulation of CD154 on T cells exclusively after
stimulation with mDCs but not in the presence of iDCs.
Several models have provided evidence that the trigger-
ing of DC differentiation and maturation is essential for the
effective activation of the immune system (41–43). In addi-
tion, it has been shown that resting donor–derived APCs
induced prolonged allograft survival (42). Furthermore, de-
fined populations of murine immature bone marrow–
derived DCs were found to induce alloantigen-specific tol-
erance in an MLR system in vitro as well as in vivo in a
heat transplant model, possibly via the induction of Tr cells
(43, 44). Therefore, the induction of tolerance versus immu-
nity may be determined by resting/iDCs versus activated/
mDCs. This would help to establish peripheral tolerance to
self. Microbial invasion results in local inflammation and
destruction of self-tissue and DC maturation mediated by
inflammatory cytokines, viral or microbial constituents
such as double-stranded RNA, LPS, and certain CpG oli-
gonucleotides or CD40 ligand. Thus, the invading micro-
organisms regulate the T cell response by transforming a
tolerance-inducing iDC via accessory signals in an immu-
nostimulatory mDC.
In conclusion, we have found that repetitive stimulation
of naive cord blood–derived CD41 T cells by allogeneic
iDCs generates T cells that display the typical properties of
Tr cells including: (a) a characteristic cytokine production
profile (IL-101/1IL-42IL-21/2IFN-g1/2); (b) intrinsic low
proliferative capacity; and (c) suppression of antigen-spe-
cific proliferation of other T cells. Our data also point to
the induction of Tr cells by iDCs as a peripheral tolerance
mechanism to self in the steady state. Our observation has
important implications for DC vaccination against infec-
tions and tumors (14), as the use of iDCs rather than mDCs
might result in tolerance induction by inducing Tr cells.
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